Kristina Lybecker
Colorado College, USA
Title: Sustainable health: The role of pharmaceutical patents
Biography
Biography: Kristina Lybecker
Abstract
As the world becomes smaller through technological advances and easier global travel, it is increasingly apparent that diseases and pandemics no longer occur in isolated pockets of distant nations, but that the health of all citizens of the world is intricately linked. Safeguarding public health is a global endeavour and a significant challenge. The emergence of new viruses and antibiotic resistant bacteria, as well as the growing global burden of non-communicable diseases, highlight the importance of maintaining a medical arsenal that keeps pace. This paper focuses on the difficulties surrounding sustainable global health and the role of pharmaceutical patents in developing new treatments and cures to combat current challenges.
Complex, Risky and Expensive
References:
Felkey, A.J. and K.M. Lybecker (2017) “ Do Restrictions Beget Responsibility? The Case of U.S. Abortion Legislation” (2017) The American Economist, forthcoming.
Lybecker, K.M. (2016) “The Biologics Revolution”, chapter 1 in “Intellectual Property Rights and the Promotion of Biologics, Medical Devices and Trade in Pharmaceuticals”, Fraser Institute, Vancouver, BC, Canada.
Lybecker, K.M. (2016) “Illicit Trade in Counterfeit Medicines”, chapter 4, in OECD Reviews of Risk Management Policies: Illicit Trade Converging Criminal Networks, OECD Publishing, 79-122.
Lybecker, K.M. (2016) “Intellectual Property Protection for Biologics: Why the Trans-Pacific Partnership (TPP) Trade Agreement Fails to Deliver”, Journal of Commercial Biotechnology, 22(1): 42-48.
Johnson, D.N.J., K.M. Lybecker, D. Nadar and A. Schultheis (2016) “Should I Buy Here, or Keep Driving? The Effect of Geographic Market Density on Retail Gas prices” Journal of Business, 01(02): 12-20